Year: 2026
Type: dissertation
Study design: Observational Study
Abstract: Genetic neurological disorders offer an opportunity to map the pathway from specific molecular pathologies to macroscopic changes in brain structure and function. This thesis uses advanced multimodal magnetic resonance imaging (MRI) to characterize the neuroimaging signatures of two such disorders in 22q11.2 deletion syndrome (22q11.2DS), the strongest known genetic risk factor for psychosis, and autosomal dominant frontotemporal dementia (FTD), a leading cause of young-onset dementia.Our work begins by establishing cerebral blood flow (CBF) derived from arterial spin labeling (ASL)-MRI as a neuroimaging biomarker in a proof-of-concept study in adults with 22q11.2DS. Regionally, elevated CBF was found in the bilateral putamen, right fusiform gyrus, and left middle temporal gyrus compared to healthy controls. This hyperperfusion was more pronounced in individuals with a history of psychotic illness, supporting CBF as a physiological correlate. We then applied ASL-MRI imaging in a longitudinal study of genetic FTD showing that CBF is sensitive to detect changes during the presymptomatic phase of the disease, and capable of tracking gene-specific trajectories of perfusion decline as well as distinguishing phenoconverters from presymptomatic non-converting counterparts. To investigate the sensitivity of neuroimaging to genetic modifying factors, we assessed the influence of TMEM106B-rs1990622G on gray matter atrophy in genetic FTD using T1-weighted structural MRI. We demonstrated that this modality could resolve the neuroprotective signature of this TMEM106B-rs1990622G through slower rates of longitudinal gray matter atrophy, particularly in FTD mutations associated with FTLD-TDP pathology. Finally, we carried out the first multi-timepoint longitudinal analysis of resting-state functional connectivity (FC) in presymptomatic genetic FTD and identified a shared, progressive decline in FC within the salience and cingulo-opercular networks across all three genetic groups, alongside gene-specific trajectories in attention networks. Lower FC in these networks also distinguished individuals who converted to the symptomatic stage from those who remained stable. Collectively, this body of work identifies and validates a suite of non-invasive imaging biomarkers sensitive to pathophysiological signatures that link genetic risk to measurable changes in the brain, thereby providing essential tools for understanding disease mechanisms and for the design of future therapeutic trials in genetic neurological disorders.
Source: TSpace (University of Toronto)
Author: Pasternak, Maurice
Institution: University of Toronto
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: 22q11.2 deletion syndrome, genetic frontotemporal dementia, cerebral blood flow, arterial spin labeling, neuroimaging biomarkers, psychosis, TMEM106B, gray matter atrophy, FTLD-TDP, resting-state functional connectivity, presymptomatic disease, phenoconversion, salience network, cingulo-opercular network, attentional networks
Open Access status: green
OpenAlex ID: W7204017575
